Pure Bioscience Organizes Advisory Panel

Mon. September 07, 2009; Posted: 11:56 PM

Sep 08, 2009 (Close-Up Media via COMTEX) -- PURE | Quote | Chart | News | PowerRating -- Pure Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced the inaugural members of its newly formed Advisory Panel: Tom Ridge, first Secretary of the U.S. Department of Homeland Security and former Governor of Pennsylvania; Scott M. Russell, Ph.D., Professor of Poultry Processing and Products Microbiology, Poultry Science Department of the University of Georgia; and Tommy G. Thompson, former U.S. Secretary of Health and Human Services and former four-term Governor of Wisconsin.

Thompson recently stepped down from the Pure Board and joined the Advisory Panel.

Michael L. Krall, President and CEO of PURE Bioscience, said, "We are pleased to announce the formation of the Advisory Panel and are honored to welcome its first members. As we continue to validate additional applications for SDC in many diverse industries and work to develop strategies for each industry, we believe it will be invaluable to receive guidance from key leaders in various market segments. Access to the experience, vision and contacts of leaders like Tom Ridge, Dr. Scott Russell and Tommy Thompson exponentially strengthens our business development program.

Secretary Tommy G. Thompson said on his appointment to the Advisory Panel, "I'm enthusiastic about the opportunity to continue to work with PURE by serving on the Advisory Panel. Although the profile in the August 23rd edition of the Sunday New York Times certainly helped raise awareness of SDC-based products, we still have a lot of work to do. I remain committed to my mission of helping to educate government agencies, businesses and consumers about the remarkable benefits of SDC-based products and how they can be instrumental in preventing transmission of dangerous human pathogens like MRSA, Norovirus and the pandemic H1N1 swine flu virus."

Secretary Tom Ridge said, "The unique chemical nature of SDC as a stable, powerful yet non-toxic antimicrobial molecule renders it critically important to the field of public safety. A multitude of possible applications exists for SDC in domestic and international industry and government, including the military, and I welcome the prospect of working with PURE Bioscience to accelerate its business strategy to commercialize SDC as a platform technology."

((Comments on this story may be sent to health@closeupmedia.com))

For full details for PURE click here.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.